- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma in New Zealand
Total 1576 results
-
Seagen Inc.TerminatedFollicular B-cell Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma RefractoryUnited States, Italy, Spain, United Kingdom, Czechia, Poland, France
-
SanofiCompletedLymphoma | Non-HodgkinUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand
-
Acerta Pharma BVAstraZenecaCompletedDiffuse Large B Cell Lymphoma | NHL | Non-hodgkin's Lymphoma | DLBCLUnited States, United Kingdom
-
MEI Pharma, Inc.TerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's LymphomaUnited States, Switzerland
-
Seagen Inc.TerminatedNon-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | DLBCL | Grade 3 Follicular LymphomaUnited States
-
ADC Therapeutics S.A.CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-Cell Lymphoma RefractoryUnited States, United Kingdom, Italy, Switzerland
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumors | B-cell Non-Hodgkin LymphomasUnited States
-
Alexion PharmaceuticalsPortola PharmaceuticalsCompletedFollicular Lymphoma (FL/Indolent NHL) | Aggressive NHL (a NHL) | Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) | T-cell Lymphoma (PTCL and CTCL) | B-cell Non Hodgkin Lymphoma (NHL)United States
-
TakedaActive, not recruitingRelapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)United States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
SecuraBioWithdrawnFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Kite, A Gilead CompanyApproved for marketingRelapsed/Refractory Diffuse Large B Cell Lymphoma | Relapsed/Refractory Primary Mediastinal B Cell Lymphoma | Relapsed/Refractory Transformed Follicular Lymphoma | Relapsed/Refractory High-Grade B-Cell LymphomaUnited States
-
TG Therapeutics, Inc.SCRI Development Innovations, LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Peripheral T-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterColumbia University; Genentech, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; National Cancer Institute (NCI); University of California... and other collaboratorsActive, not recruitingHodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Eisai Inc.CompletedLymphoma, B-CellUnited States
-
Genentech, Inc.CompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, Canada, France, Italy, Germany, Netherlands
-
PfizerCompletedLymphoma, B-CellUnited States, Spain, France, Switzerland, United Kingdom, Belgium, Germany
-
Wyeth is now a wholly owned subsidiary of PfizerEmergent Product Development Seattle LLCTerminated
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin LymphomaUnited States, Australia
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompleted
-
Molecular Templates, Inc.No longer availableNon-Hodgkin's B-cell LymphomaUnited States
-
Nektar TherapeuticsRecruitingNon-Hodgkin Lymphoma | Relapsed/Refractory Diffuse Large B-cell LymphomaUnited States
-
Spectrum Pharmaceuticals, IncTerminated
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type | Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell TypeUnited States, Saudi Arabia
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States
-
CelgeneThe Leukemia and Lymphoma SocietyCompletedWaldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | B Cell Non-Hodgkin's LymphomaUnited States
-
Gilead SciencesWithdrawnDiffuse Large B-cell Lymphoma | NHL | Non Hodgkin's Lymphoma | Aggressive NHLUnited States
-
Mirati Therapeutics Inc.TerminatedHodgkin Lymphoma | Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)United States
-
AbbVieRecruitingDiffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | B Cell MalignanciesUnited States, Israel, Australia, France, United Kingdom, Belgium, Spain
-
National Cancer Institute (NCI)TerminatedUnspecified Childhood Solid Tumor, Protocol Specific | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Childhood Chronic Myelogenous Leukemia | Cutaneous B-cell Non-Hodgkin Lymphoma | Hepatosplenic T-cell Lymphoma | Intraocular Lymphoma | Recurrent Childhood Acute Lymphoblastic... and other conditionsUnited States, Canada
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); AmgenActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 Positive | Stage I Diffuse Large B-Cell Lymphoma | Stage II Diffuse Large B-Cell Lymphoma | Stage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | B-Cell Non-Hodgkin Lymphoma | Metastatic Pancreatic Carcinoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Pancreatic Carcinoma | Refractory T-Cell... and other conditionsUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedLymphoma Non-Hodgkin | Agressive Lymphoma | Diffuse-large B-cell Lymphoma (DLBCL)United States, Canada
-
Spectrum Pharmaceuticals, IncCompletedLymphoma, B-CellUnited States
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Merck Sharp & Dohme LLCRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaAustralia, Spain, United States, France, Hungary, New Zealand, Poland, Serbia, Canada, Romania
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Australia
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
Hackensack Meridian HealthJanssen Scientific Affairs, LLC; Genentech, Inc.Active, not recruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
CephalonCompletedNon-Hodgkin's Lymphoma (NHL)United States, Belgium, Israel
-
MorphotekNational Cancer Institute (NCI); Children's Oncology GroupCompletedUnspecified Childhood Solid Tumor, Protocol Specific | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
Novartis PharmaceuticalsRecruitingB-cell Non-Hodgkin Lymphoma (B-NHL) | B-cell Acute Lymphoblastic Leukemia (B-ALL)Japan, Italy, Spain, Belgium, Singapore, France, United States, Israel
-
Memorial Sloan Kettering Cancer CenterNorthwestern University; Merck Sharp & Dohme LLC; Weill Medical College of Cornell... and other collaboratorsCompletedLymphoma | Hodgkin's DiseaseUnited States
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkins Lymphoma (B-NHL)United States, Spain, United Kingdom, Netherlands
-
Icahn School of Medicine at Mount SinaiUnknownMultiple Myeloma | Hodgkin's Disease | Chronic Lymphocytic Lymphoma | Relapsed Non-Hodgkin's LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Non-Hodgkin LymphomaUnited States, Canada, Puerto Rico, Australia, Switzerland